HRT for Perimenopause: A Beginner's Guide (Without the Scare Tactics)

I spent two years too scared to consider HRT. My mother had been told in 2003, when the WHI study made headlines, that hormones cause cancer — and that fear traveled cleanly into me. When I finally read the actual study, and the twenty years of follow-up research that came after, I felt something close to grief for all the women who suffered through perimenopause believing their only option was to white-knuckle it.

This is the guide I wish someone had handed me at 42.

What HRT actually is

Hormone replacement therapy — also called menopause hormone therapy (MHT) — replaces the estrogen, progesterone, and (sometimes) testosterone that your ovaries stop producing in reliable amounts during perimenopause and after menopause.

Modern HRT comes in three pieces, used in combination depending on whether you still have a uterus:

• Estrogen — usually transdermal (patch, gel, or spray). Treats hot flashes, night sweats, mood, joint pain, vaginal dryness, brain fog.
• Progesterone — oral micronized (Prometrium) at bedtime. Protects the uterine lining and aids sleep.
• Testosterone — off-label in the US, often a compounded cream. Treats libido, energy, motivation.

The WHI study, in plain English

In 2002, the Women's Health Initiative published findings that hormone therapy slightly increased the risk of breast cancer, stroke, and blood clots. The headlines were catastrophic. What didn't make the headlines:

• The average participant was 63 years old — well past menopause.
• They used oral conjugated equine estrogens (Premarin) and a synthetic progestin (medroxyprogesterone) — not the molecules used today.
• The increased breast cancer risk was real but small (less than the risk from drinking 2 glasses of wine a night).
• For women who started HRT in their 50s — closer to the modern protocol — subsequent analyses found reduced all-cause mortality.

Today, the North American Menopause Society, the Endocrine Society, the American College of Obstetricians and Gynecologists, and the British Menopause Society all support HRT for symptomatic women under 60 and within 10 years of menopause as low-risk and beneficial.

Who is HRT for?

Generally appropriate for:

• Women with bothersome perimenopause/menopause symptoms.
• Women under 60 or within 10 years of their final period.
• Women with early menopause (before 45) — HRT until age 51 is considered standard of care.

Discuss carefully (sometimes still appropriate) with:

• History of breast cancer or estrogen-sensitive cancer.
• Personal history of blood clots or stroke.
• Active liver disease.
• Unexplained vaginal bleeding (work this up first).

Bioidentical vs. compounded vs. synthetic

What to expect when you start

1. Weeks 1–2: Possible bloating, breast tenderness, slight nausea as your body adjusts.
2. Weeks 3–6: Sleep usually improves first. Night sweats often resolve.
3. Months 2–3: Energy, mood, brain fog, joint pain typically improve.
4. Months 3–6: Libido, vaginal dryness, skin elasticity continue to improve.
5. Recheck thyroid 6–8 weeks in if you have any thyroid condition.

How to find a doctor who knows what they're doing

1. Search the NAMS Menopause Practitioner Directory for a NCMP-credentialed doctor.
2. Ask if they prescribe transdermal estradiol and oral micronized progesterone (the modern protocol).
3. Ask if they're comfortable adjusting for chronic conditions (Hashimoto's, lupus, fibro, etc.).
4. Telehealth menopause clinics (Midi, Alloy, Evernow) are good options if local options are limited.

Questions to bring to your appointment

• Based on my history, am I a candidate for transdermal estrogen?
• What dose would you start me at, and when do we recheck?
• Do I need progesterone? Oral micronized?
• What symptoms should improve, and on what timeline?
• What would prompt us to adjust or stop?
• How does this interact with my other medications and conditions?

HRT is not a moral question. It's a medical one. You deserve to make it with current information, not twenty-year-old headlines.